Definition and management of radioactive iodine-refractory differentiated thyroid cancer

M Schlumberger, M Brose, R Elisei… - The lancet Diabetes & …, 2014 - thelancet.com
For some patients with metastatic disease from differentiated thyroid cancer, remarkable results
can be achieved with eradication of tumour cells through radioactive iodine (131I) uptake…

The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway

…, JA Knauf, JM Shirokawa, J Wang, B Ouyang, R Elisei… - Oncogene, 2000 - nature.com
Activating mutations of RAS are thought to be early events in the evolution of thyroid follicular
neoplasms. We used a doxycycline-inducible expression system to explore the acute …

A joint statement from the American thyroid association, the European association of nuclear medicine, the European thyroid association, the society of nuclear …

…, VJ Bernet, P Bourguet, C Draganescu, R Elisei… - Thyroid, 2021 - liebertpub.com
Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

[HTML][HTML] Involvement of protein kinase Cε (PKCε) in thyroid cell death: a truncated chimeric PKCε cloned from a thyroid cancer cell line protects thyroid cells from …

JA Knauf, R Elisei, D Mochly-Rosen, T Liron… - Journal of Biological …, 1999 - ASBMB
The protein kinase C (PKC) family has been implicated in the regulation of apoptosis. However,
the contribution of individual PKC isozymes to this process is not well understood. We …

Conditional apoptosis induced by oncogenic ras in thyroid cells

JM Shirokawa, R Elisei, JA Knauf, T Hara… - Molecular …, 2000 - academic.oup.com
Mutations of ras are tumor-initiating events for many cell types, including thyrocytes. To
explore early consequences after oncogenic Ras activation, we developed a doxycycline-…

Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for …

R Gonsky, JA Knauf, R Elisei, JW Wang… - Nucleic acids …, 1997 - academic.oup.com
The mRNAs of transiently expressed proteins such as cytokines and proto-oncogenes are
commonly subject to rapid transcriptional activation and degradation. Transcript turnover is …

[HTML][HTML] Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with …

…, L Pezzullo, MG Castagna, A Angeloni, R Elisei… - Biomarker …, 2023 - Springer
Medullary Thyroid Carcinoma (MTC) is a rare neuroendocrine tumour whose diagnosis
includes evaluating calcitonin serum levels, which can present fluctuations unrelated to MTC. …

{sup 131}-I post-surgical thyroid remnant ablation in patients with differentiated thyroid cancer (Dtc): the advantage of using low diagnostic tracer doses

F Bianchi, MG Castagna, R Elisei, M Capezzone… - Thyroid, 2005 - osti.gov
Full text: Patients with DTC are usually treated with total thyroidectomy followed by {sup 131}I
for remnant ablation. Controversies remain concerning both the {sup 131}I activity to be …

[PDF][PDF] Involvement of Protein Kinase C (PKC) in Thyroid Cell Death

JA Knauf, R Elisei, D Mochly-Rosen, T Liron, XN Chen… - 1999 - researchgate.net
The protein kinase C (PKC) family has been implicated in the regulation of apoptosis. However,
the contribution of individual PKC isozymes to this process is not well understood. We …

[PDF][PDF] Seza A. Gulec, Sukhjeet Ahuja, 4 Anca M. Avram, 4, 5 Victor J. Bernet, 6, 7 Patrick Bourguet, 8 Ciprian Draganescu, 8 Rosella Elisei, 9, 10 Luca Giovanella, 11 …

M Luster, WJG Oyen, J Smit, RM Tuttle - THYROID, 2021 - academia.edu
Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …